Titre : Hypercémentose

Hypercémentose : Questions médicales fréquentes

Termes MeSH sélectionnés :

Galectin 3
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hypercémentose : Questions médicales les plus fréquentes", "headline": "Hypercémentose : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hypercémentose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-13", "dateModified": "2025-04-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hypercémentose" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies des dents", "url": "https://questionsmedicales.fr/mesh/D014076", "about": { "@type": "MedicalCondition", "name": "Maladies des dents", "code": { "@type": "MedicalCode", "code": "D014076", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.793" } } }, "about": { "@type": "MedicalCondition", "name": "Hypercémentose", "alternateName": "Hypercementosis", "code": { "@type": "MedicalCode", "code": "D006936", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Kamil Górski", "url": "https://questionsmedicales.fr/author/Kamil%20G%C3%B3rski", "affiliation": { "@type": "Organization", "name": "Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland." } }, { "@type": "Person", "name": "Izabela Polkowska", "url": "https://questionsmedicales.fr/author/Izabela%20Polkowska", "affiliation": { "@type": "Organization", "name": "Department and Clinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences, 20-950 Lublin, Poland." } }, { "@type": "Person", "name": "Bernard Turek", "url": "https://questionsmedicales.fr/author/Bernard%20Turek", "affiliation": { "@type": "Organization", "name": "Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland." } }, { "@type": "Person", "name": "Andrzej Bereznowski", "url": "https://questionsmedicales.fr/author/Andrzej%20Bereznowski", "affiliation": { "@type": "Organization", "name": "Division of Veterinary Epidemiology and Economics, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Nowoursynowska 159c, 02-776 Warsaw, Poland." } }, { "@type": "Person", "name": "Bruno Maureille", "url": "https://questionsmedicales.fr/author/Bruno%20Maureille", "affiliation": { "@type": "Organization", "name": "Univ. Bordeaux, CNRS, Ministère de la Culture, PACEA, UMR 5199, F-33600 Pessac, France." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Structure of Galectin-3 bound to a model membrane containing ganglioside GM1.", "datePublished": "2022-08-19", "url": "https://questionsmedicales.fr/article/35986516", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.bpj.2022.08.018" } }, { "@type": "ScholarlyArticle", "name": "The prognostic role of galectin-3 and endothelial function in patients with heart failure.", "datePublished": "2022-08-17", "url": "https://questionsmedicales.fr/article/35975796", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5603/CJ.a2022.0074" } }, { "@type": "ScholarlyArticle", "name": "Prognosis value of galectin-3 in patients with dilated cardiomyopathy: a meta-analysis.", "datePublished": "2024-04-23", "url": "https://questionsmedicales.fr/article/38680895", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7717/peerj.17201" } }, { "@type": "ScholarlyArticle", "name": "Association of Urine Galectin-3 With Cardiorenal Outcomes in Patients With Heart Failure.", "datePublished": "2023-06-09", "url": "https://questionsmedicales.fr/article/37301248", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cardfail.2023.05.018" } }, { "@type": "ScholarlyArticle", "name": "Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases.", "datePublished": "2023-05-01", "url": "https://questionsmedicales.fr/article/37175823", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms24098116" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système stomatognathique", "item": "https://questionsmedicales.fr/mesh/D009057" }, { "@type": "ListItem", "position": 3, "name": "Maladies des dents", "item": "https://questionsmedicales.fr/mesh/D014076" }, { "@type": "ListItem", "position": 4, "name": "Hypercémentose", "item": "https://questionsmedicales.fr/mesh/D006936" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hypercémentose - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hypercémentose", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hypercémentose", "description": "Comment diagnostiquer l'hypercémentose ?\nQuels examens sont nécessaires pour confirmer l'hypercémentose ?\nQuels signes radiographiques indiquent l'hypercémentose ?\nL'hypercémentose est-elle visible à l'œil nu ?\nPeut-on confondre l'hypercémentose avec d'autres conditions ?", "url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hypercémentose", "description": "Quels sont les symptômes de l'hypercémentose ?\nL'hypercémentose provoque-t-elle des douleurs ?\nY a-t-il des signes cliniques visibles ?\nL'hypercémentose affecte-t-elle la mastication ?\nPeut-on avoir des gencives enflammées avec l'hypercémentose ?", "url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hypercémentose", "description": "Comment prévenir l'hypercémentose ?\nLes visites chez le dentiste aident-elles à prévenir l'hypercémentose ?\nUne alimentation saine peut-elle prévenir l'hypercémentose ?\nLe tabagisme influence-t-il l'hypercémentose ?\nLes traitements orthodontiques affectent-ils l'hypercémentose ?", "url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hypercémentose", "description": "Quel traitement est recommandé pour l'hypercémentose ?\nDes médicaments sont-ils nécessaires pour l'hypercémentose ?\nQuand faut-il envisager une intervention chirurgicale ?\nL'hypercémentose nécessite-t-elle un suivi régulier ?\nPeut-on prévenir l'hypercémentose par des soins dentaires ?", "url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hypercémentose", "description": "Quelles complications peuvent survenir avec l'hypercémentose ?\nL'hypercémentose peut-elle entraîner des infections ?\nPeut-on perdre des dents à cause de l'hypercémentose ?\nL'hypercémentose affecte-t-elle la santé générale ?\nDes douleurs chroniques peuvent-elles résulter de l'hypercémentose ?", "url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hypercémentose", "description": "Quels sont les facteurs de risque de l'hypercémentose ?\nL'âge influence-t-il le risque d'hypercémentose ?\nLes maladies systémiques augmentent-elles le risque ?\nLe stress a-t-il un impact sur l'hypercémentose ?\nLes antécédents familiaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hypercémentose ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par radiographies dentaires montrant un épaississement du ciment." } }, { "@type": "Question", "name": "Quels examens sont nécessaires pour confirmer l'hypercémentose ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des examens cliniques et des radiographies sont nécessaires pour évaluer l'état des dents." } }, { "@type": "Question", "name": "Quels signes radiographiques indiquent l'hypercémentose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "On observe un épaississement du cimentum sur les radiographies, souvent autour des racines." } }, { "@type": "Question", "name": "L'hypercémentose est-elle visible à l'œil nu ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle nécessite des radiographies pour être détectée, car elle est asymptomatique au début." } }, { "@type": "Question", "name": "Peut-on confondre l'hypercémentose avec d'autres conditions ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec d'autres maladies parodontales, nécessitant un diagnostic précis." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hypercémentose ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "L'hypercémentose est souvent asymptomatique, mais peut causer des douleurs dentaires dans certains cas." } }, { "@type": "Question", "name": "L'hypercémentose provoque-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle est généralement asymptomatique, mais des douleurs peuvent survenir si des complications se développent." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques visibles ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de signes cliniques visibles, mais des radiographies peuvent montrer des anomalies." } }, { "@type": "Question", "name": "L'hypercémentose affecte-t-elle la mastication ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "En général, elle n'affecte pas la mastication, sauf si elle entraîne des complications dentaires." } }, { "@type": "Question", "name": "Peut-on avoir des gencives enflammées avec l'hypercémentose ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'hypercémentose elle-même ne cause pas d'inflammation des gencives, mais des maladies parodontales peuvent coexister." } }, { "@type": "Question", "name": "Comment prévenir l'hypercémentose ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène bucco-dentaire et consulter régulièrement un dentiste aide à prévenir." } }, { "@type": "Question", "name": "Les visites chez le dentiste aident-elles à prévenir l'hypercémentose ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des visites régulières permettent de détecter précocement les problèmes dentaires et d'agir." } }, { "@type": "Question", "name": "Une alimentation saine peut-elle prévenir l'hypercémentose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée contribue à la santé dentaire, mais ne prévient pas spécifiquement l'hypercémentose." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il l'hypercémentose ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme peut aggraver les problèmes parodontaux, augmentant le risque d'hypercémentose." } }, { "@type": "Question", "name": "Les traitements orthodontiques affectent-ils l'hypercémentose ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements orthodontiques peuvent parfois exacerber l'hypercémentose, nécessitant une surveillance." } }, { "@type": "Question", "name": "Quel traitement est recommandé pour l'hypercémentose ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend des symptômes; souvent, aucune intervention n'est nécessaire si asymptomatique." } }, { "@type": "Question", "name": "Des médicaments sont-ils nécessaires pour l'hypercémentose ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Généralement, aucun médicament n'est requis, sauf en cas de douleur ou d'infection associée." } }, { "@type": "Question", "name": "Quand faut-il envisager une intervention chirurgicale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une intervention chirurgicale est rare et envisagée uniquement si des complications graves surviennent." } }, { "@type": "Question", "name": "L'hypercémentose nécessite-t-elle un suivi régulier ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier est conseillé pour surveiller l'évolution et prévenir d'éventuelles complications." } }, { "@type": "Question", "name": "Peut-on prévenir l'hypercémentose par des soins dentaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des soins dentaires réguliers peuvent aider à prévenir les maladies parodontales qui aggravent l'hypercémentose." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'hypercémentose ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des douleurs dentaires, des infections ou des problèmes de mastication." } }, { "@type": "Question", "name": "L'hypercémentose peut-elle entraîner des infections ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, si elle est associée à des maladies parodontales, le risque d'infection augmente." } }, { "@type": "Question", "name": "Peut-on perdre des dents à cause de l'hypercémentose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, si elle est associée à des maladies parodontales, cela peut entraîner une perte dentaire." } }, { "@type": "Question", "name": "L'hypercémentose affecte-t-elle la santé générale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "En général, l'hypercémentose n'affecte pas la santé générale, mais des complications dentaires peuvent avoir un impact." } }, { "@type": "Question", "name": "Des douleurs chroniques peuvent-elles résulter de l'hypercémentose ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs chroniques peuvent survenir si des complications dentaires se développent." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'hypercémentose ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des maladies parodontales, des traitements orthodontiques et le tabagisme." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'hypercémentose ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'hypercémentose augmente avec l'âge en raison de l'usure dentaire et des maladies parodontales." } }, { "@type": "Question", "name": "Les maladies systémiques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies systémiques, comme le diabète, peuvent augmenter le risque d'hypercémentose." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur l'hypercémentose ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut contribuer à des comportements nuisibles pour la santé dentaire, augmentant le risque." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de problèmes dentaires peuvent augmenter le risque d'hypercémentose." } } ] } ] }

Sources (10000 au total)

The prognostic role of galectin-3 and endothelial function in patients with heart failure.

Heart failure (HF) is nowadays classified as HF with reduced ejection fraction (HFrEF), HF with mildly reduced EF (HFmrEF), and HF with preserved EF (HFpEF). Endothelial dysfunction (assessed by flow-... In this study we prospectively enrolled 340 patients with stable ischemic HF. We assessed the brachial artery FMD, carotid-femoral PWV, and galectin-3 levels, and patients were followed up for MACE ac... Interestingly, the FMD values exhibited a stepwise improvement according to left ventricular ejection fraction (LVEF) (HFrEF: 4.74 ± 2.35% vs. HFmrEF: 4.97 ± 2.81% vs. HFpEF: 5.94 ± ± 3.46%, p = 0.01)... Flow-mediated dilatation displayed a linear improvement with LVEF in patients with ischemic HF. Deteriorated values are associated with MACE. Higher levels of galectin-3 might be used for risk stratif...

Prognosis value of galectin-3 in patients with dilated cardiomyopathy: a meta-analysis.

Accurate prediction and assessment of myocardial fibrosis (MF) and adverse cardiovascular events (MACEs) are crucial in patients with dilated cardiomyopathy (DCM). Several studies indicate that galect... A comprehensive search was conducted in PubMed, EMBASE, the Cochrane Library, and Web of Science for relevant studies up to August 2023. The hazard ratios (HRs) of gal-3 for MACEs in DCM patients, and... Seven studies, encompassing 945 patients, met the eligibility criteria. In DCM patients, abnormally elevated gal-3 levels were indicative of an increased MACEs risk (HR = 1.10, 95% CI [1.00-1.21], I... This study's findings suggest that elevated gal-3 levels significantly correlate with increased MACE risk in DCM, highlighting its potential as a biomarker. However, significant heterogeneity among st... CRD42023471199....

Association of Urine Galectin-3 With Cardiorenal Outcomes in Patients With Heart Failure.

Approaches to distinguishing pathological cardiorenal dysfunction in heart failure (HF) from functional/hemodynamically mediated changes in serum creatinine are needed. We investigated urine galectin-... We measured urine galectin-3 in 2 contemporary HF cohorts: the Yale Transitional Care Clinic (YTCC) cohort (n = 132) and the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone A... In the YTCC cohort, there was significant effect modification between higher urine galectin-3 and lower estimated glomerular filtration rates (eGFRs) (P... Urine galectin-3 levels correlated with an established biomarker of renal fibrosis in 2 cohorts and was able to differentiate high- vs low-risk phenotypes of chronic kidney disease in HF. These proof-...

Prognostic significance of serum galectin-3 in hospitalized patients with COVID-19.

There are no major tools that could predict disease severity in COVID-19. The aim of this study is to evaluate if serum galectin-3 levels can identify disease progression in COVID-19.... Patients that were hospitalized due to COVID-19 between March and June 2020 were included in this cross-sectional prospective study. Baseline demographic and clinical data in addition to levels of ser... A total of 175 patients were included in the study and among these, 64 patients formed the severe illness group whereas 111 comprised the non-severe illness group. There was statistically significant ... In conclusion, our results indicated that galectin-3 had moderate power in outlining disease severity and the need for ICU transfer throughout the clinical course in COVID-19....

Association between sleep patterns and galectin-3 in a Chinese community population.

Irregular sleep patterns have been associated with inflammation. Galectin-3, a novel biomarker, plays an important role in inflammation. We investigated the relationship between sleep patterns and gal... A total of 1,058 participants from the Shenzhen-Hong Kong United Network on Cardiovascular Disease study were included in the analysis. Age and sex-adjusted linear regression models were employed to i... Of study participants, the mean age was 45.3 years and 54.3% were women. Waist circumference, natural logarithm (ln)-transformed triglyceride, and ln-transformed high sensitivity C-reactive protein we... Our study provides evidence of a significant association between sleep disturbance and elevated galectin-3 level, independent of traditional metabolic biomarkers. Screening and interventions on galect...

Elevated galectin-3 levels detected in women with hyperglycemia during early and mid-pregnancy antagonizes high glucose - induced trophoblast cells apoptosis via galectin-3/foxc1 pathway.

This study was to evaluate plasma galectin-3 levels from early pregnancy to delivery and explore the effects of galectin-3 on the function of trophoblast cells under high glucose exposure.... The plasma galectin-3 levels were quantified by enzyme-linked immunosorbent assay (ELISA) in the China National Birth Cohort (CNBC) at Peking University First Hospital, and the underlying signaling pa... Significantly higher galectin-3 levels were found in patients with gestational diabetes mellitus (GDM group; n = 77) during the first and second trimesters than that in healthy pregnant women (HP grou... Future studies were required to validate whether plasma galectin-3 might become a potential biomarker for hyperglycemia during pregnancy. Elevated galectin-3 levels might be a vital protective mechani...

Galectin-3, a damage-associated molecular pattern, in tears of patients with vernal keratoconjunctivitis.

Galectin-3 is a damage-associated molecular pattern (DAMPs), released from damaged or dying cells. In this study, we investigated the concentration and source of galectin-3 in the tears of patients wi... Clinical and experimental.... We measured the concentration of galectin-3 in tear samples from 26 patients with VKC and 6 healthy controls by enzyme-linked immunosorbent assay (ELISA). The expression of galectin-3 in cultured huma... High concentrations of galectin-3 were detected in the tears of patients with VKC. The concentration showed significant correlation with the severity of corneal epithelial damage. Stimulation of cultu... The concentrations of galectin-3 in the tears of patients with VKC may represent a biomarker of the severity of corneal epithelial damage....